Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. One promising strategy is the formation of creative partnerships between patients and their healthcare teams. Here are four key strategies to achieve this: 1.Shared

Education 59

Education Cardiovascular Disease Kidney Disease Diabetes 59

Cardiometabolic Health Congress

AUGUST 14, 2024

The focus will be on the intricate interplay between cardiorenal and metabolic conditions, such as type 2 diabetes, cardiovascular disease, and chronic kidney disease, driven by lifestyle and health factors. Attendees will gain valuable clinical insights and explore cutting-edge therapies aimed at improving overall health outcomes. “Dr.

CME 72

CME Education Diabetes Innovation 72

Journal of Cardiovascular Pharmacology

MARCH 4, 2024

Treatment of risk factors such as diabetes and cigarette smoking can benefit patients with PAD. Patients should have adequate blood pressure and lipid control to decrease clinical manifestations and symptoms of PAD. Treatment of risk factors such as diabetes and cigarette smoking can benefit patients with PAD.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Blood Pressure Risk Factors Nursing 40

GEMMS

MAY 22, 2024

These advancements, alongside software enhancements, enable early detection of cardiac diseases, empowering healthcare providers to make evidence-based decisions and tailor appropriate patient care plans. This improves diagnostic accuracy and ultimately leads to better patient outcomes.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

Cardiometabolic Health Congress

NOVEMBER 8, 2023

2023, the American Heart Association (AHA) issued a presidential advisory on the urgency of this systemic disorder involving heart disease, kidney disease, diabetes and obesity. In its advisory, the AHA stressed an interdisciplinary team approach emphasizing social determinants of health, shortcomings in current efforts, and knowledge gaps.

Certification 52

Certification Nursing Kidney Disease Education 52

ADN Center of Excellence

OCTOBER 28, 2024

Its insidious nature often occurring without warning has profound implications for patient outcomes, underscoring the need for proactive prevention, rapid response, and advanced treatment strategies. Often called the "silent killer," stroke is a leading cause of death and disability worldwide. www.adncoe.com

Stroke 59

Stroke Strokes Education Innovation 59

GEMMS

MARCH 28, 2023

An EHR system is more than just a platform to store patient information digitally. It can convert that data into valuable insights, which helps medical practitioners provide better patient care. Highly rated EHR systems remarkably impact operations, patient care, and profits.

Patient Care 52

Patient Care Quality of Life Technology Medicaid 52

GEMMS

JUNE 25, 2024

Pregnancy-related complications, such as preeclampsia and gestational diabetes, also elevate the chances of developing heart disease later in life. Additionally, conditions like diabetes can significantly increase the likelihood of heart disease in women, who may also experience silent heart attacks due to altered pain perception.

Heart Disease 52

Heart Disease Risk Factors Diet Chest Pain 52

Cardiometabolic Health Congress

OCTOBER 25, 2024

Florez, MD, PhD , explored the future of precision medicine in diabetes. Morris, MD, led discussions on LDL-lowering therapy, Martha Gulati, MD, MS, FACC, FAHA, FASPC , FESC, presented on cardiovascular outcomes in women, and Christie M. Aronne, MD , discussed advances in obesity pharmacology, while Virend K.

CME 64

CME Innovation Education Atherosclerosis 64

Cardiometabolic Health Congress

AUGUST 23, 2024

Our expert faculty at CMHC delve into critical issues, offering insights on managing very low LDL-C, addressing concerns with statins and new-onset diabetes, and exploring the residual ASCVD risk beyond LDL-C, among other essential topics, in the CMHC Lipid Management Hub.

Dementia 52

Dementia Cholesterol Risk Factors CME 52

Cardiometabolic Health Congress

JULY 17, 2024

Staying informed about these cutting-edge developments is critical for providing exceptional patient care. Join us as we examine the landmark approvals that are revolutionizing patient outcomes. The first half of 2024 has ushered in a wave of transformative FDA approvals in cardiorenal metabolic health.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

The Beat Blog

MAY 2, 2023

3 Access to timely quality care becomes more and more of a challenge for too many rural communities – and hospitals and payers continue to look for solutions to address this intractable problem. The demand for cardiovascular care, for example, continues to grow at an almost exponential rate. So what is the way forward? 1 [link] 2.

Atrial Fibrillation 52

Atrial Fibrillation Cardiovascular Disease Technology Hospital 52